Iprex ® HFA Inhaler

Ipratropium Bromide
Anticholinergic (Antiasthma)

Indication:

Asthma and Chronic Obstructive Pulmonary Diseases including chronic bronchitis and emphysema.

Dosage & Administration:

Adults :1-2 puffs (20 mg/puff) 3-4 times daily. Children: 1-2 puffs 2-3 times daily.

Preparation:

Iprex^® inhaler : Each canister contains Ipratropium Bromide BP 4 mg (minimum 200 puffs). Each puff delivers Ipratropium
Bromide BP 20 µg.